• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS Back to Search Results
Catalog Number 08837031190
Medical Device Problem Codes False Positive Result (1227); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/09/2025
Type of Reportable Event Malfunction
Event or Problem Description
There was an allegation of questionable elecsys anti-hcv ii results for 1 patient sample on a cobas e 801 analytical unit compared to two competitor analyzers.The customer questioned the initial result as it did not match the patient's clinical history.The e801 analyzer result was 2.19 coi and the repeat result was 2.38 coi, both interpreted as reactive.The yhlo analyzer result was 0.17 coi, interpreted as non-reactive.The abbott analyzer result was 0.13 s/co.The yhlo analyzer result was deemed correct.No questionable results were reported outside of the laboratory.
 
Additional Manufacturer Narrative
The analyzer serial number is (b)(6).The calibration and qc recovery data provided was acceptable.The investigation is ongoing.
 
Additional Manufacturer Narrative
Calibration was last performed on (b)(6) 2025 and was acceptable.A sample-specific discrepancy is likely.The specificity of elecsys ahcvii is less than 100%.All initially reactive samples (results = 0.9 coi) should be re-determined in duplicate with the elecsys anti-hcv ii assay.For repeatedly reactive samples, confirmation via supplemental methods (e.G.Immunoblot or detection of hcv rna) is recommended.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-HCV II
Common Device Name
ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key23416582
Report Number1823260-2025-04409
Device Sequence Number10431823
Product Code MZO
UDI-Device Identifier07613336166970
UDI-Public07613336166970
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K221693
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number08837031190
Device Lot Number846034
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/09/2025
Supplement Date Received by Manufacturer11/03/2025
Initial Report FDA Received Date10/29/2025
Supplement Report FDA Received Date11/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-